Skip to main content

Table 1 Demographic and clinicopathological characteristics of the main study population

From: MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression

Parameters   Intestinal (n = 86) Diffuse (n = 42) Total (N = 128) p-value
Age in years (median, IQR)   79 (72–85) 78 (68–84) 78 (70–78) 0.239
Sex (male)   61 (70.9 %) 24 (57.1 %) 85 (66.4 %) 0.163
T-stage T1 13 (15.1 %) 3 (7.1 %) 16 (12.5 %) 0.328
  T2 36 (41.9 %) 15 (35.7 %) 51 (39.8 %)
  T3 31 (36.0 %) 22 (52.4 %) 53 (41.4 %)
  T4 6 (7.0 %) 2 (4.8 %) 8 (6.2 %)
N-stage* Positive (N1-3) 57 (66.3 %) 39 (92.9 %) 96 (75.0 %) 0.001
M1 Positive (M1) 29 (33.7 %) 20 (47.6 %) 49 (38.3 %) 0.175
Grading* G1 6 (7.0 %) 0 (0) 6 (4.7 %) <0.001
  G2 45 (52.3 %) 1 (2.4 %) 46 (35.9 %)
  G3 35 (40.7 %) 41 (97.6 %) 76 (59.4 %)
Localisation* Cardia 30 (34.9 %) 6 (14.3 %) 36 (28.1 %) 0.042
  Corpus 33 (38.4 %) 23 (54.8 %) 56 (43.8 %)
  Antrum 23 (26.7 %) 13 (31.0 %) 36 (28.1 %)
  1. Comparison between intestinal and diffuse type tumors was done by Fisher's exact test with significant differences (p < 0.05) marked by an asterisk. IQR: interquartile range; Grading: G1: well differentiated, G2: moderately differentiated, G3: poorly differentiated